CIAS
IART icon

Capital Investment Advisory Services’s Integra LifeSciences IART Stock Holding History

Capital Investment Advisory Services’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-106
Closed -$6K – 887
2019
Q3 		$6K Hold
106
– – ﹤0.01% 1090
2019
Q2 		$6K Buy
+106
New +$5.46K ﹤0.01% 1093

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital Investment Advisory Services's IART Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 106 shares — an estimated $6K sold.

Capital Investment Advisory Services first reported a position in IART in Q2 2019 and held it in 2 quarters. The position peaked at $6K in Q3 2019. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 106 Integra LifeSciences shares in Q4 2019, an estimated $6K.
  • Capital Investment Advisory Services first reported a position in Integra LifeSciences in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's Integra LifeSciences position peaked at $6K in Q3 2019.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.